Abstract
Universal Precautions as recommended by the Centers for Disease Control (CDC) in 1987 (1) and updated in 1988 (2) have been widely adopted and form an integral part of the regulatory activity of the Occupational Safety and Health Administration (OSHA) and state regulatory agencies. Universal precautions as promulgated by the CDC imply the use of Blood and Body Fluid Isolation for all patients regardless of any lack of evidence of an infection with hepatitis B virus (HBV), human immunodeficiency virus (HIV), or other blood-borne infection. The implementation of universal precautions has raised many issues which have not been officially addressed by the CDC or OSHA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
CDC. 1987. Recommendations for the prevention of HIV transmission in health-care settings. MMWR. 36(suppl no. 2S):3s.
CDC. 1988. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis 3 virus, and other bloodborne pathogens in health-care settings. MMWR. 37:377–388.
Garner, J.S. and B.P. Simmons. 1983, Guideline for isolation precautions in hospitals, Infect. Control 4:245–325.
CDC. 1981. Pneumocystis pneumonia-Los Angeles. MMWR. 30:250–252.
CDC. 1987. AIDS: Recommendations and guidelines, November 1982-November 1986. (U.S. Government Printing Office: 1987-732-950/40505), US Department of Health and Human Services, Public Health Service, Atlanta.
NCCLS. 1987. Protection of laboratory workers from infectious disease transmitted by blood and tissue; Proposed Guideline. NCCLS Document M29-P. National Committee for Clinical Laboratory Standards, Villanova.
Department of Labor, Department of Health and Human Services. 1987. Joint advisory notice: Protection against occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). US Department of Labor, US Department of Health and Human Services, Washington.
OSHA. 1988. Enforcement procedures for occupational exposure to hepatitis 3 virus (HBV), human immunodeficiency virus (HIV), and other blood-borne infectious agents in health care facilities. OSHA Instruction CPL 2-2.44. OSHA, Washington.
OSHA. 1988. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). OSHA instruction CPL 2-2.44A, August 15, 1988. OSHA, Washington.
NCCLS. 1988. Protection of laboratory workers from infectious diseases transmitted by bloodr body fluids, and tissue; Tentative Guideline. NCCLS Document M29-T. National Committee for Clinical Laboratory Standards, Villanova.
Ziza, J.M., F. Brun-Vezinet, A. Venet, C.H. Rouzioux, J. Traversat, B. Israel-Biet, F. Barre-Sinoussi, J.C. Chermann, and P. Godeau. 1985. Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid on AIDS-related complex with lymphoid interstitial pneumonitis. N. Engl. J. Med. 313:183.
Grady, G.F., V.A. Lee, A.M. Prince, G.L. Gitnick, K.A. Fawaz, G.N. Vyas, M.D. Levitt, J.R. Senior, J.T. Galambos, T.E. Bynum, J.W. Singleton, B.F. Clowdus, K. Akdamar, R.D. Aach, E.I. Winkelman, G.M. Schiff, and T. Hersh. 1978. Hepatitis B immune globulin for accidental exposures among medical personnel: Final report of a multi-center controlled trial. J. Infect. Dis. 138:625–638.
Seeff, L.B. 1978. Type B hepatitis after needlestick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann. Intern. Med. 88:285–293.
Vlahov, D. and B.F. Polk. 1987. Transmission of human immunodeficiency virus within the health care setting. Occupational Medicine: State of the Art Rev. 2:429–450.
Gerberding, J.L., C.E. Bryant-LeBlanc, K. Nelson, A.R. Moss, D. Osmund, H.F. Chambers, J.R. Carlson, W.L. Drew, J.A. Levy, and M.A. Sande. 1987. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J. Infect. Dis. 156:1–8.
CDC. 1988. Quarterly report to the domestic policy council on the prevalence and rate of spread of HIV and AIDS — united States. MMWR. 37:551–559.
CDC. 1987. Human immunodeficiency virus in the united States: A review of current knowledge. MMWR. 36 (suppl. no. s-6)
CDC. 1987. Human immunodeficiency virus infection in transfusion recipients and their family members. MMWR. 36:137–140.
CDC. 1987. Trends in human immunodeficiency virus infection among civilian applicants for military service — united States, October 1985–December 1986. MMWR. 36:273–274.
Lifson, A.R., T.W. Bodecker, J.L. Barnhart, P.M. O’Malley, G.F. Lemp, N.A. Hessol, D.R. Franks, J.J. Cambell, D. Werdegar, H.W. Jaffe, and G.W. Rutherford. 1987. AIDS in the S.F. city cohort study. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington.
Robert-Guroff, M., S.H. Weiss, J.A. Giron, A.M. Jennings, I.B. Margolis, W.A. Blattner, and R.C. Gallo. 1986. Prevalence of antibodies to HTLV-I,-II, and-III in in travenous drug abusers from an AIDS endemic region. JAMA. 155:151–152.
Friedland, G.H. and R.S. Klein. 1987. Transmission of the human immunodeficiency virus. N. Engl. J. Med. 317:1125–1135.
CDC. 1987. HIV infection and pregnancies in sexual partners of HIV-seropositive hemophiliac men — United States. MMWR. 36:593–595.
Hoofnagle, J.H. 1985. Hepatitis. Principles and Practices of Infectious Diseases, 2nd Ed. G.L. Mandell, R.G. Douglas, and J.E. Bennett (eds.), John Wiley & Sons, New York.
CDC. 1984. Adult immunization: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. (suppl no. IS): 5s-6s.
Wormser, G. P, C.S. Rabkin, and C. Jolin. 1988. Frequency of nosocomial transmission of HIV infection among health care workers. N. Engl. J. Med. 319:307–308.
CDC. 1988. update: Acquired immunodeficiency syndrome and human immunodeficiency virus infection among health-care workers. MMWR. 37:229–239.
Redfield, R.R. and D.S. Burke. 1988. HIV infection: The clinical picture. Scientific American 259:90–98.
Palmer, D.L., M. Barash, R. King, and F. Neil. 1983. Hepatitis among hospital employees. Western J. Med. 138:519–523.
Favero, M.S., J.P. Petersen, W.W. Bond. 1986. Transmission and control of laboratory-acquired hepatitis infection. Laboratory Safety: Principles and Practices. B.M. Miller, D.H.M. Groschel, J.H. Richardson, D. Vesley, J.R. Songer, R.D. Housewright, and W.E. Barkley (eds.), American Society for Microbiology, Washington.
Ranki, A., S.L. Valle, M. Krohn, J. Antonen, J.P. Allain, M. Leuther, G. Franchini, and K. Krohn. 1987. Long latency precedes overt seroconversion in sexually transmitted human immunodeficiency virus infection. Lancet ii:589–593.
Casareale, D., S. Dewhurst, J. Sonnabend, F. Sinangil, D.T. Purtilo, and D.H. Volsky. 1984–1985. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Res. Hum. Retroviruses 1:407–421.
Feorino, P., B. Forrester, C. Schable, D. Warfield, G. Schochetman. 1987. Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture. J. Clin. Microbiol. 25:2344–2346.
Gerberding, J.L. 1986. The University of California-San Francisco Task Force on Aids: Recommended infection-control policies for patients with human immunodeficiency virus infection. N. Engl. J. Med. 315:1562–1563.
Lynch, P., M.N. Jackson, M.J. Cummings, and W.E. Stamm. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann. Intern. Med. 107:243–250.
CDC. 1985. Recommendations of the immunization practices advisory committee. MMWR. 34:313–324, 329-335.
CDC. 1985. Recommendations of the immunization advisory committee. MMWR. 34:313–324, 329-335.
CDC. 1986. Recommendations of the immunization practices advisory committee — Update on hepatitis B prevention. MMWR. 36:353–366.
Ruprecht, R.M., L.G. O’Bien, L.D. Rossoni, and S. Nusinoff-Lehrman 1986. Suppression of mouse viremia and retroviral disease by 3′-azido-3′-deoxythymidine. Nature 323:467–469.
Sharpe, A.H., R. Jaenisch, and R.M. Ruprecht. 1987. Retroviruses and mouse embryos: A rapid model for neuro virulence and transplacental antiviral therapy. Science 236:1671–1674.
Ou, C.Y., S. Kwok, S.W. Mitchell, D.H. Mack, J.J. Snisky, J.W. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295–297.
CDC. 1988. 1988 Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infec tion with human immunodeficiency virus. MMWR. 37(suppl. no. S-4):1S–22S.
Koop, C.E. 1987. Surgeon General’s Report on acquired immunodeficiency syndrome. U.S. Department of Health and Human Services, Public Health Service, Washington.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Bauer, S. (1990). CDC, NCCLS, and OSHA Guidelines for Universal Precautions: Who is right and are the Guidelines Practical?. In: Cundy, K.R., Kleger, B., Hinks, E.T., Miller, L.A. (eds) Infection Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5724-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5724-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5726-1
Online ISBN: 978-1-4684-5724-7
eBook Packages: Springer Book Archive